| Ms Maria Elizabeth Perry, CNM, RNC | |
|
Bldg H100, Santa Margarita Road, Attention: Code Cs-pa, Camp Pendleton, CA 92055 | |
| (760) 725-0681 | |
| Not Available |
| Full Name | Ms Maria Elizabeth Perry |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | Bldg H100, Santa Margarita Road, Camp Pendleton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417940438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maria Elizabeth Perry, CNM, RNC 4531 Carnaby Ct, Carlsbad, CA 92010-2879 Ph: (760) 434-0141 | Ms Maria Elizabeth Perry, CNM, RNC Bldg H100, Santa Margarita Road, Attention: Code Cs-pa, Camp Pendleton, CA 92055 Ph: (760) 725-0681 |
News Archive
Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, today announced that COO and Head of R&D, Bruce Given, M.D., presented data on the Phase 1 clinical study of ARC-520, the company's clinical candidate for the treatment of chronic hepatitis B infection, at the HepDART 2013 conference being held on The Big Island, Hawaii.
Almost a year in the making, a federal plan to prioritize research on the potential environmental, health, and safety (EHS) impacts of nanoscale materials has so many failings that its begs the question as to whether the government's 13-agency nanotechnology research effort is able to deliver an effective risk research strategy, according to David Rejeski, head of the Wilson Center's Project on Emerging Nanotechnologies.
In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough.
The New York Times: "Dr. Harold E. Varmus, a Nobel Prize-winning biologist and former director of the National Institutes of Health, will become director of the National Cancer Institute, the White House announced Monday. President Obama selected Dr. Varmus, who is now president of Memorial Sloan-Kettering Cancer Center in New York, after a lengthy search. Dr. Varmus is expected to shake up the much-criticized federal cancer program" (Pear, 5/17).
› Verified 6 days ago